ATS Red Journal
banner
ajrcmb.bsky.social
ATS Red Journal
@ajrcmb.bsky.social
Posting content from the American Journal of Respiratory Cell and Molecular Biology; follows do not indicate endorsement. #ATS #AJRCMB #RedJournal #medsky

https://www.atsjournals.org/journal/ajrcmb
Pinned
📣Call for Papers!📣

We aim to showcase work that investigates the underlying mechanisms for lung repair in health and disease, including lung development

📆Deadline: December 31, 2025

🔬Learn More Here: tinyurl.com/ye24jb76

🖱️Submit here: tinyurl.com/yahzwj8k

@atscommunity.bsky.social #medsky
Vaping-induced Oxidation of Cannabidiol Causes Adduction of TOP2A and Interferes with Cellular Proliferation

CBD vaping products pose health risks due to contaminants and CBD quinone (CBDQ), which inhibits cell-cycle genes and airway function
@ilonajaspers.bsky.social

🔗 tinyurl.com/3y4pjwv3
November 13, 2025 at 4:42 PM
Docosahexaenoic Acid and Its Metabolites Protect against Ozone-induced Pulmonary Inflammation
@atscommunity.bsky.social #medsky

🔗 tinyurl.com/3hutsvyk
November 12, 2025 at 5:36 PM
Reposted by ATS Red Journal
Advances in medicine can move quickly. How does the ATS update its guidelines to ensure they come out in a timely manner? Julio Ramirez, MD, explains how he and his fellow committee members updated the guidelines for community-acquired pneumonia on the ATS Breathe Easy podcast:
ATS Breathe Easy - Guiding Care of Patients with Community-Acquired Pneumonia
As new studies uncover better treatments and practices, it is important to develop new clinical practice guidelines to ensure patients receive the best care. Julio A. Ramirez, MD, Norton Healthcare…
youtu.be
November 11, 2025 at 5:01 PM
Matrix Softness Induces an Afibrogenic Lipofibroblast Phenotype in Fibroblasts from Patients with Idiopathic Pulmonary Fibrosis
@atscommunity.bsky.social #medsky

🔗 tinyurl.com/4rw46yzx
November 11, 2025 at 5:44 PM
📣Call for Papers!📣

We aim to showcase work that investigates the underlying mechanisms for lung repair in health and disease, including lung development

📆Deadline: December 31, 2025

🔬Learn More Here: tinyurl.com/ye24jb76

🖱️Submit here: tinyurl.com/yahzwj8k
November 11, 2025 at 3:52 AM
Pulmonary Fibrosis—Focusing on the Future: Aspen Lung Conference 2024 Summary
@atscommunity.bsky.social

🔗 tinyurl.com/yj3ctnrk
November 11, 2025 at 3:49 AM
ANT1 Deficiency Impairs Macrophage Metabolism and Migration, Protecting Against Emphysema in COPD

Alterations of mitochondrial function through adenine nucleotide translocate show therapeutic target to halt lung inflammation in COPD
@atscommunity.bsky.social #medsky

🔗 tinyurl.com/39etsrkx
November 7, 2025 at 7:25 PM
Less Is More: Silencing ANT1 Calms Lung Inflammation in Chronic Obstructive Pulmonary Disease
@atscommunity.bsky.social #medsky

🔓 Open Access

🔗 tinyurl.com/yc2hj8tu
November 6, 2025 at 6:49 PM
Reposted by ATS Red Journal
📣Call for Papers!📣

We aim to showcase work that investigates the underlying mechanisms for lung repair in health and disease, including lung development

📆Deadline: December 31, 2025

🔬Learn More Here: tinyurl.com/ye24jb76

🖱️Submit here: tinyurl.com/yahzwj8k
October 30, 2025 at 6:48 PM
Pioglitazone Reverses Alcohol-induced HIV Replication & IL-1β Expression in Alveolar Macrophages

Identified the ERK1/2-PPARgamma-NFKB/p65 pathway as a mechanism for alcohol-induced HIV replication & proinflammatory activation in AMs
@emorydeptofmed.bsky.social #medsky

🔗 tinyurl.com/4jjazfnn
November 5, 2025 at 4:36 PM
Reversing Alcohol-Dependent Effects on HIV Replication: Are There Roles for Pioglitazone and N-acetylcysteine?
@atscommunity.bsky.social #medsky

🔓 Open Access

🔗 tinyurl.com/4yrawvm4
November 5, 2025 at 4:30 PM
Reposted by ATS Red Journal
⏰There's less than two days left to submit for #ATS2026!⏰

The ATS is accepting scientific abstracts and case reports on all aspects of respiratory disease, critical care, and sleep medicine for ATS 2026

Deadline is 5 p.m., Nov. 5, 2025. Submit today: conference.thoracic.org/program/call...
November 4, 2025 at 2:23 PM
Reposted by ATS Red Journal
The VESTIGE trial tested how well dupilumab worked for patients with moderate to severe asthma. But how does this medication work? Payel Gupta, MD, explains on a special collab episode with the ATS Breathe Easy podcast and Allergy & Asthma Network's The Itch podcast.

Watch now: youtu.be/56Q9LQrMLDs
November 4, 2025 at 7:30 PM
Insights into the Cellular and Molecular Mechanisms behind the Antifibrotic Effects of Nerandomilast

Nerandomilast dedifferentiates human lung myofibroblasts and mitigates features of vascular dysfunction in vitro and in vivo
#medsky

🔓 Open Access

🔗 tinyurl.com/46svbpb4
November 4, 2025 at 6:15 PM
Nerandomilast – A Multifrontal Therapeutic Approach to Lung Fibrosis
@atscommunity.bsky.social #medsky

🔓 Open Access

🔗 tinyurl.com/2kp8ufke
Nerandomilast – A Multifrontal Therapeutic Approach to Lung Fibrosis | American Journal of Respiratory Cell and Molecular Biology
tinyurl.com
November 4, 2025 at 6:11 PM
Development of a Polidocanol-based Human In Vitro Model to Explore Airway Epithelial Repair

A versatile human in vitro model to study mechanisms of susceptibility to airway injury as well as human airway repair and regeneration
@staabweijnitz.bsky.social #medsky

🔗 tinyurl.com/385zx98f
November 3, 2025 at 5:28 PM
Closing the Gap: Use of Polidocanol to Study Human Airway Epithelial Repair
@atscommunity.bsky.social #medsky

🔓 Open Access

🔗 tinyurl.com/ysdpvx9v
November 3, 2025 at 5:15 PM
The latest issue of the #AJRCMB is now live!

Take a look: t.co/NMszdL5I0G

@atscommunity.bsky.social #medsky
October 31, 2025 at 5:17 PM
📣Call for Papers!📣

We aim to showcase work that investigates the underlying mechanisms for lung repair in health and disease, including lung development

📆Deadline: December 31, 2025

🔬Learn More Here: tinyurl.com/ye24jb76

🖱️Submit here: tinyurl.com/yahzwj8k
October 30, 2025 at 6:48 PM
Single-Cell RNA Sequencing Identifies a Unique Macrophage Population in a Mouse Model of Ozone-induced Asthma Exacerbation
@atscommunity.bsky.social #medsky

🔗 tinyurl.com/45a9umm8
October 30, 2025 at 6:43 PM
eNAMPT Is a Novel DAMP and Therapeutic Target in Human and Murine Pulmonary Fibrosis
@atscommunity.bsky.social #medsky

🔗 tinyurl.com/u9unw8bk
tinyurl.com
October 29, 2025 at 4:41 PM
Reposted by ATS Red Journal
Getting treatment for COPD is crucial, but controller medications can be expensive. Antonio Anzueto, MD, explains the importance of getting patients medication on the ATS Breathe Easy podcast. Support for this podcast is brought to you by Viatris and Theravance BioPharma

Watch: youtu.be/srUEiAWGHYU
October 28, 2025 at 3:00 PM
Warifteine Alleviates Acute Lung Injury and Inhibits NETosis by Decreasing Reactive Oxygen Species–induced Gasdermin D Oligomerization
@atscommunity.bsky.social #medsky

🔗 tinyurl.com/4x3bz5t9
October 28, 2025 at 4:32 PM
Pirfenidone Mitigates Transforming Growth Factor-β–induced Inflammation after Viral Infection
@atscommunity.bsky.social #medsky

🔗 tinyurl.com/5n6fz4e3
October 24, 2025 at 3:33 PM